Acute hepatocellular injury associated with zafirlukast [2]

Journal of Hepatology

Volumn 35, Issue 4, 2001, Pages 541-542

  Molés, José Ramón ^a   Primo, Joaquín ^a   Fernández, Julio M ^a   Hinojosa, JoaquÍn E ^a  

^a HOSPITAL DE SAGUNTO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BUDESONIDE; CYTOCHROME P450 2C9; FORMOTEROL; GAMMA GLUTAMYLTRANSFERASE; SALBUTAMOL; ZAFIRLUKAST;

ADULT; ANOREXIA; ASTHENIA; ASTHMA; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; JAUNDICE; LETTER; LIVER CELL DAMAGE; LIVER FUNCTION TEST; MALAISE; PRIORITY JOURNAL;

ACUTE DISEASE; ANTI-ASTHMATIC AGENTS; FEMALE; HUMANS; LIVER DISEASES; MIDDLE AGED; TOSYL COMPOUNDS;

EID: 0034793041     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00124-6     Document Type: Letter

References (11)

1. Zafirlukast: A review of its pharmacology and therapeutic potential in the management of asthma
2. Leukotriene-receptor antagonists
3. Long-term safety and efficacy of zafirlukast in the treatment of asthma: Interim results of an open-label extension trial
4. Correction: Liver injury and rosiglitazone
5. Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast
6. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting
7. Drug-induced liver diseases
8. Clinical diagnostic scale: A useful tool in the evaluation of suspected hepatotoxic adverse drug reactions